Literature DB >> 6441714

The dexamethasone suppression test and thyroid stimulating hormone response to TRH in RDC schizoaffective patients.

H Sauer, K G Koehler, H Sass, C Hornstein, H W Minne.   

Abstract

The dexamethasone suppression test (DST) brought to light significantly more non-suppression of cortisol secretion in RDC schizoaffectives of the depressed (89%) and of the manic type (67%) than in RDC schizophrenia (25%). However, only in the RDC endogenous depressives, whose pathological DST rate was 57%, was the thyroid stimulating hormone (TSH) response to thyrotrophin releasing hormone (TRH) found to be significantly "blunted". It is suggested that the DST results can be interpreted as partially validating DSM-III's wide major affective disorder since this concept also encompasses all cases with mood-incongruent psychotic features. Furthermore, it is hypothesized that the coupling of DST non-suppression and TSH "blunting" may be important for defining a valid depressive subgroup within these extended clinical boundaries for affective illness.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441714     DOI: 10.1007/bf00381358

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  13 in total

1.  Thyrotrophin-releasing hormone (TRH) stimulation test in manic-depressive illness.

Authors:  C Kirkegaard; N Bjørum; D Cohn; U B Lauridsen
Journal:  Arch Gen Psychiatry       Date:  1978-08

2.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

3.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

4.  Behavioral and endocrine responses of schizophrenic patients to TRH (protirelin).

Authors:  A J Prange; P T Loosen; I C Wilson; H Y Meltzer; V S Fang
Journal:  Arch Gen Psychiatry       Date:  1979-09

5.  The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups.

Authors:  J Mendlewicz; G Charles; J M Franckson
Journal:  Br J Psychiatry       Date:  1982-11       Impact factor: 9.319

6.  Dexamethasone suppression test in primary depression: significance of family history and psychosis.

Authors:  M V Rudorfer; H G Hwu; P J Clayton
Journal:  Biol Psychiatry       Date:  1982-01       Impact factor: 13.382

7.  The dexamethasone suppression test in the clinical setting.

Authors:  D L Evans; G B Burnett; C B Nemeroff
Journal:  Am J Psychiatry       Date:  1983-05       Impact factor: 18.112

8.  Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression.

Authors:  B J Carroll; J F Greden; M Feinberg; N M James; R F Haskett; M Steiner; J Tarika
Journal:  Psychiatry Res       Date:  1980-07       Impact factor: 3.222

9.  Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review.

Authors:  P T Loosen; A J Prange
Journal:  Am J Psychiatry       Date:  1982-04       Impact factor: 18.112

10.  The dexamethasone suppression test in mania.

Authors:  P M Graham; J Booth; G Boranga; S Galhenage; C M Myers; C L Teoh; L S Cox
Journal:  J Affect Disord       Date:  1982-09       Impact factor: 4.839

View more
  2 in total

1.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

2.  Judgement of the hypothalamic-pituitary-adrenocortical function in psychiatric patients by betamethasone-induced cortisol suppressibility.

Authors:  S Kasper; P Vecsei; P Richter; D Haack; K Diebold; L Katzinski
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.